Drug interference with MIBG uptake in a patient with metastatic paraganglioma

British Journal of Radiology

Volumn 77, Issue 918, 2004, Pages 525-527

  Zaplatnikov, K ^a   Menzel, C ^a   Dobert N ^a   Hamscho, N ^a   Kranert, W T ^a   Gotthard, M ^b   Behr, T M ^b   Grunwald F ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; ALCOHOL; AMPHETAMINE DERIVATIVE; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; COCAINE; DIAMORPHINE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; METHADONE; METOCLOPRAMIDE; MIRTAZAPINE; THYROID HORMONE; (3 IODOBENZYL)GUANIDINE; ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; NARCOTIC AGENT; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CASE REPORT; DIAGNOSTIC ERROR; DRUG ABSORPTION; DRUG COMPETITION; DRUG LABELING; DRUG METABOLISM; DRUG MIXTURE; DRUG UPTAKE; DRUG USE; HUMAN; MALE; METASTASIS POTENTIAL; NAUSEA; PARAGANGLIOMA; POSITRON EMISSION TOMOGRAPHY; TISSUE DISTRIBUTION; TUMOR LOCALIZATION; WHOLE BODY SCINTISCANNING; ADDICTION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG INTERACTION; METASTASIS; METHODOLOGY; SCINTISCANNING;

3-IODOBENZYLGUANIDINE; ADULT; ANTINEOPLASTIC AGENTS; DRUG INTERACTIONS; FLUORODEOXYGLUCOSE F18; HUMANS; IODINE RADIOISOTOPES; MALE; METHADONE; NARCOTICS; PARAGANGLIOMA; RADIOPHARMACEUTICALS; SUBSTANCE-RELATED DISORDERS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 3042639353     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/23668769     Document Type: Article

References (11)

1. Proff P, Babin-Ebell J, Müller JG, Hopp H, Elert O. Paragangliom der Aorta ascendens. Zeitschrift für Herz-, Thorax-und Gefäßchirurgie 2000;14:258-63.
2. Razakaboay M, Maillefert JF, Wendling D, Juvin R, Toussirot E, Tavernier C, et al. Bone metastases from a paraganglioma. A review of five cases. Rev Rhum Engl Ed 1999;66:86-91.
3. Hiller WF, Scheumann GF, Dralle H. Diagnosis and surgical treatment of extra-adrenal pheochromocytoma. Chirurg 1993; 64:36-42.
4. Bomanji J, Britton KE, Ur E, Hawkins L, Grossmann A, Besser GM. Treatment of malignant pheochromozytoma, paraganglioma and carcinoid tumors with 131I-metaiodbenzylguainidine. Nucl Med Commun 1993;14:856-61.
5. Sisson JC, Frager MS, Valk TW, Gross MD, Swanson DP, Wieland DM, et al. Scintigraphic localisation of pheochromocytoma. N Engl J Med 1981;305:12-7.
6. Loh KC, Fitzgerald PA, Matthay KK, Yeo PP, Price DC. The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients. J Endocrinol Invest 1997;20:648-58.
7. Bomanji JB, Hyder SW, Gaze MN, Gacinovic S, Costa DC, Coulter C, et al. Functional imaging as an aid to decisionmaking in metastatic paraganglioma. Br J Radiol 2001;74: 266-9.
8. Shapiro B, Sisson JC, Wieland DM, Mangner TJ, Zempel SM, Mudgett E, et al. Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience. J Nucl Biol Med 1991;35: 269-76.
9. Solanki KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled metaiodobenzylguanidine (MIBG). Nucl Med Commun 1992;13: 513-21.
10. Wafelman AR, Hoefnagel CA, Maes RA, Beijnen JH. Radioiodinated metaiodbenzylguanidine: a review of its biodisribution and pharmacokinetics, drug interactions, cytotoxity and dosimetry. Eur J Nucl Med 1994;21:545-59.
11. Schwarz KB, Driver I, Lewis IJ, Taylor RE. Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis. Br J Radiol 1997;70:90-2. Comment on: Britton KE, Br J Radiol 1997;70:969.